Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: Contrasts between oral cavity and cutaneous malignancy

Laryngoscope

Volumn 116, Issue 3 SUPPL. 2, 2006, Pages 1-15

  Civantos, Francisco J ^a,b   Moffat, Frederick L ^a   Goodwin, William J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Carcinoma; Head and neck cancer; Lymphatic metastases; Melanoma; Sentinel lymph node biopsy; Skin neoplasms; Squamous cell

Indexed keywords

RADIOISOTOPE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIP CANCER; LYMPH FLOW; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MERKEL CELL TUMOR; MOUTH CANCER; NECK DISSECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; SPINAL NERVE; SQUAMOUS CELL CARCINOMA; COMPARATIVE STUDY; HEAD AND NECK TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; PROSPECTIVE STUDY; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33645529151     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000200750.74249.79     Document Type: Article

References (50)

1. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. ArchSurg 1992;127:392-399.
2. Morton DL, Wen D-R, Foshag LJ, et al. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751-1756.
3. Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin North Am 1996;5:33.
4. Leong SP. Selective sentinel lymphadenectomy for malignant melanoma. Surg Clin North Am 2003;83:157.
5. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453.
6. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391.
7. O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461.
8. Jansen L, Koops HS, Nieweg OE, et al. Sentinel node biopsy for melanoma in the head and neck region. Head Neck 2000;22:27.
9. deWilt JH, Thompson JF, Uren RF, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004;239:544.
10. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003;10:21.
11. Nopajoroonsri C, Simon GT. Phagocytosis of colloidal carbon in a lymph node. Am J Pathol 1971;65:25-42.
12. Nopajaronnsri C, Luk SC, Simon GT. Ultrastructure of the normal lymph node. Am J Pathol 1971;65:1-24.
13. Sainte-Marie G, Peng FS. Diffusion of a lymph-carried antigen in the fiber network of the lymph node of the rat. Cell Tissue Res 1986;245:481-486.
14. Luk SC, Nopajaroonsri C, Simon GT. The architecture of the lymph node and hemolymph node. Lab Invest 1973;29:258-265.
15. Kligerman J, Lima RA, Soares JR, et al. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168:391-392.
16. Pitman KT, Johnson JT, Myers EN, et al. Effectiveness of the selective neck dissection for the management of the clinically negative neck. Arch Otolaryngol 1997;123:917-922.
17. McGuirt WF, Johnson JT, Myers EN, et al. Floor of mouth carcinoma. The management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 1995;121:278-282.
18. Shah JP, Andersen PE. Evolving role of modifications in neck dissection for oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1995;33:3-8.
19. Ross GL, Shoaib T, Soutar DS, et al. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002;128:1287-1290.
20. Shoaib T, Soutar DS, MacDonald DG, et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer 2001;91:2077-2083.
21. Civantos FJ, Gomez C, Duque C, et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck 2003;25:1
22. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel node identification in patients with melanoma. Ann Surg 1996;223:217-214.
23. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-260.
24. Messina JL, Reintgen DS, Cruise CW, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389.
25. Altinyollar H, Berberoglu U, Celen O. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol 2002;28:72-74.
26. Weisberg NK, Bertagnolli MM, Becker DS. Combined sentinel lymphadenectomy and Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2000;43:483-488.
27. Reschly MJ, Messina J, Zaulyanov LL, et al. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2003;29:135-140.
28. Stoekli SJ, Steinert H, Pfaltz M, et al. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2001;125:221-226.
29. Zitsch RP III, Todd DW, Renner GJ, et al. Intraoperative radiolymphoscintigraphy for detection of occult nodal metastasis in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2000;122:662-666.
30. Taylor RJ, Wahl RL, Sharma PK, et al. Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg 2001;127:970-974.
31. Lindberg R. Distribution of cervical lymph node metastasis from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446-1449.
32. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg 1985;150:414-421.
33. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck Surg 1988;10:160-167.
34. Shah JP, Andersen PE. The impact of patterns of nodal metastasis on modifications of neck dissection. Ann Surg Oncol 1994;1:521-532.
35. Fincher TR, O'Brien JC, McCarty TM, et al. Patterns of drainage and recurrence following sentinel lymph node biopsy for cutaneous melanoma of the head and neck. Arch Otolaryngol Head Neck Surg 2004;130:844.
36. Ross GL, Shoaib T, Scott J, et al. The learning curve for sentinel node biopsy in malignant melanoma. Br J Plast Surg 2002;55:298-301.
37. Shah JP, Kraus DH, Dubner S, Sarkar S. Patterns of regional lymph node metastases from cutaneous melanomas of the head and neck. Am J Surg 1991;162:320-323.
38. Armitage P, Berry B, Matthews JNS. Statistical Methods in Medical Research , 4th ed. Oxford: Blackwell Scientific; 2002.
39. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976.
40. Schmalbach CE, Nussenbaum B, Rees RS. et al. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg 2003;129:61-65.
41. O'Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310-314.
42. Terrell JE, Ronis DL, Fowler KE, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:401-408.
43. Chepeha DB, Taylor RJ, Chepeha JC, et al. Functional assessment using Constant's Shoulder Scale after modified radical and selective neck dissection. Head Neck 2002;24:432-436.
44. Tannis PJ, Boom RPA, Koops HS, et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001;8:222-226.
45. Chung CH, Parker JS, Yabrough WG, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004;5:489-500.
46. Becker MT, Shores CG, Yarbrough WG. Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:21-27.
47. Raja S, ElHefnay T, Kelly LA, et al. Temperature-controlled primer limit for multiplexing of rapid, quantitative reverse transcription-PCR assays: application to intraoperative cancer diagnostics. Clin Chem 2002;48:1329-1337.
48. Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998;124:582-587.
49. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. J Am Acad Dermatol 1989;21:241-248.
50. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002;28:268-273.